calendar
5,854 catalysts · 18,987 approval · 5,990 phase readout · 5,000 device 510k · 4,728 grant · 3,126 8k filing · 2,000 device pma
5,854 catalysts · 18,987 approval · 5,990 phase readout · 5,000 device 510k · 4,728 grant · 3,126 8k filing · 2,000 device pma
no tagged catalysts yet
GM grant. $224,737. PI: Elisabetta Liverani
NS grant. $110,118. PI: RODNEY P GUTTMANN
AI grant. $16,500. PI: TERRY L. SHEPPARD
AI grant. $457,875. PI: MELISSA J CAIMANO
AI grant. $596,318. PI: Neal Mathew Alto
AI grant. $649,484. PI: VLADIMIR P BADOVINAC
DK grant. $117,000. PI: VERA FRIDMAN
AI grant. $190,825. PI: Jessica Lin
GM grant. $142,182. PI: Kushal Seetharam
AI grant. $790,946. PI: Nathan Schmidt
AI grant. $435,875. PI: Vincent Tam
AI grant. $790,847. PI: Zandrea Ambrose
AI grant. $235,500. PI: Paul D Gershon
AI grant. $490,704. PI: Amanda Martinot
AI grant. $444,125. PI: Judith A Woodfolk
AI grant. $515,625. PI: Dmitry Lyumkis
GM grant. $462,500. PI: Yuuta Imoto
AI grant. $460,625. PI: YONG-RUI ZOU
AI grant. $729,189. PI: Adam Lee Bailey
AI grant. $195,750. PI: Liudi Tang
AI grant. $440,000. PI: SATISH N NADIG
GM grant. $160,566. PI: Mohammad Razavi Rizi
Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIS LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India, Manufactured for: UNICHEM PHARMACEUTICALS (USA), INC., East Brunswick, NJ 08816, NDC 29300-187-01 — Reason: cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits. — Status: Ongoing
Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLumber.com, 2618 San Miguel Drive, Suite #296, Newport Beach, CA 92660 — Reason: Marketed without an Approved NDA/ANDA: FDA analysis found this product to contain tadalafil — Status: Ongoing
Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-231-01. — Reason: Presence of Foreign Tablets/Capsules — Status: Ongoing
Diclofenac Sodium, Topical Gel, 3%, 100 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1363-7 — Reason: Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%. — Status: Ongoing
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313 — Reason: CGMP Deviations: product found to contain lead. — Status: Ongoing
HD grant. $743,116. PI: Christopher Bennett Geyer
NS grant. $544,568. PI: BRUCE D TRAPP
AI grant. $427,625. PI: Ryan Zander
NS grant. $620,504. PI: John Nicholas Betley
NS grant. $243,750. PI: Xiaofeng Guo
NS grant. $80,000. PI: Roxana Gabriela Burciu
NS grant. $508,533. PI: JAVIER F MEDINA
NS grant. $644,345. PI: Christopher G. Favilla
NS grant. $25,000. PI: Maria de Lourdes Gamez Tansey
TW grant. $372,306. PI: Farrah Jasmine Mateen
GM grant. $191,972. PI: June Bryan de la Pena
AI grant. $407,326. PI: STEPHEN C JAMESON
GM grant. $423,734. PI: Nir Yakoby
DC grant. $490,487. PI: David W Raible
AI grant. $441,204. PI: Derek J Bays
AI grant. $452,375. PI: Adam Mor
AI grant. $508,750. PI: Yongqiang Feng
AI grant. $429,499. PI: WERNER A BRAUN
AI grant. $404,570. PI: STEPHEN J MCSORLEY
AI grant. $744,328. PI: Katherine S Ralston
AI grant. $670,529. PI: Michael Joseph Rybak
AI grant. $681,110. PI: Daniel Swale
AI grant. $825,054. PI: Jennifer Melinda Bomberger